InsiderTrades

Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.

Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0001567619-22-012339 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-06-03 2022-06-01 TMCI Owens Daniel E. Chief HR Off M - OptEx $7.03 +1,000 11.7K +9% +$7,030
D 2022-06-03 2022-06-01 TMCI Owens Daniel E. Chief HR Off S - Sale+OE $16.67 -1,000 10.7K -9% -$16.7K
D 2022-06-03 2022-06-01 TMCI Owens Daniel E. Chief HR Off M - OptEx $0.00 -1,000 198.6K -0.5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-06-01 M A 1,000 $7.03 11,700 D — — (F2) Includes 6,700 RSUs.
2 Common Common Stock 2022-06-01 S D 1,000 $16.67 10,700 D — — (F2) Includes 6,700 RSUs.
3 Derivative Stock Option (Right to Buy) 2022-06-01 M D 1,000 $0.00 198,625 D $7.03 · — to 2031-02-02 1,000 Common Stock (F3) The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.